Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Early treatment of children's hair loss, which can be caused by various factors, is important due to its emotional impact.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Detailed history and physical examination are crucial for diagnosing hair loss.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Targeted testing for telogen effluvium patients can save healthcare costs.

Gender affects the symptoms and severity of systemic lupus erythematosus.

Dupilumab can cause rare side effects like a rash on the face and neck.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Laser hair reduction can sometimes cause a rare skin condition called Fox-Fordyce disease.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

A man got heart and swelling issues from a hair loss medication, so doctors advise careful use, especially in people with past health problems.

Pigmented papules on the ear can be a rare skin condition called cutaneous amyloidosis, treatable with topical tretinoin.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.